317 / 881
Heart
Quantec:
„old“ tolerance dose
for clinically relevant endpoints
40 Gy/ 2 Gy ?
Darby (breast cancer patients):
no threshold
7%/Gy increased risk
AB survivors registry:
increasing risk for CAD from mSv doses
Treatment: symptomatic